A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT Meeting Abstract
| Authors: | Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K. |
| Abstract Title: | A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 461s |
| Language: | English |
| ACCESSION: | WOS:000276606606017 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.9001 |
| Notes: | Meeting Abstract: 9001 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
